Stock listing
IXHL Stock Price, News, Filings & Events — Incannex Healthcare Inc.
Selected listing: IXHL · NASDAQ · USD · US
This page tracks Incannex Healthcare Inc.'s IXHL:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following IXHL:NASDAQ. IXHL:NASDAQ is the stock-level entry point for investors researching Incannex Healthcare Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Incannex Healthcare Inc. (Ticker: IXHL) is a public company based in America, focusing on the healthcare sector. With a market capitalization of approximately $35.3 million, Incannex is involved in developing innovative therapies and solutions. The company is dedicated to advancing healthcare through its research and product offerings.
- Ticker
- IXHL:NASDAQ
- Asset type
- Stock
- Market cap
- $42.7M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
Incannex Healthcare Inc. IXHL:NASDAQ stock context
This page tracks Incannex Healthcare Inc.'s IXHL:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following IXHL:NASDAQ. IXHL:NASDAQ is the stock-level entry point for investors researching Incannex Healthcare Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Incannex Healthcare Inc. (Ticker: IXHL) is a public company based in America, focusing on the healthcare sector. With a market capitalization of approximately $35.3 million, Incannex is involved in developing innovative therapies and solutions. The company is dedicated to advancing healthcare through its research and product offerings.
Latest news from Incannex Healthcare Inc.
Incannex Announces First Patient Dosed in DReAMzz Phase 2 Study of IHL-42X
August 25, 2026
Incannex Commences Participant Screening in DReAMzz Phase 2 Study of IHL-42X for Obstructive Sleep Apnea
July 23, 2026
Incannex Secures U.S. Patent Grant for IHL-42X in Obstructive Sleep Apnea
June 25, 2026
Incannex Receives A$6.0 Million R&D Tax Incentive Refund for FY25, Further Strengthening Balance Sheet and Financial Flexibility
June 10, 2026
Incannex Announces Initiation of Research Coverage by Alliance Global Partners
June 9, 2026
Research Incannex Healthcare Inc.
Incannex Healthcare Inc. investor report
Review AI stock analysis and investor report context for IXHL:NASDAQ.
Incannex Healthcare Inc. company profile
View the public company page for Incannex Healthcare Inc. on 6ix.
Incannex Healthcare Inc. news
Read company news and market updates connected to Incannex Healthcare Inc..
Incannex Healthcare Inc. investor events
Find investor webinars, events, and replay context for Incannex Healthcare Inc..